Former GOP Sen. Ben Sasse On ‘Nasty Drug’ to Treat Stage 4 Cancer

Pancreatic cancer is one of the hardest cancers to detect and treat, and it is also decidedly lethal. In December, doctors informed him that he had three to four months to live, The Post reported. “I’m at Day 99 or something since then, and I’m doing a heck of a lot better than I was doing at Christmas,” the former Nebraska senator and University of Florida president said.

Sasse is participating in a clinical trial for daraxonrasib, a targeted therapy aimed at slowing pancreatic cancer by blocking the mutant proteins that drive the disease in most patients.